🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Dr. Agarwal's Eye Hospital Limited DRAGARWQ NSE

· India
https://www.dragarwal.com

Dr. Agarwal's Eye Hospital Limited engages in the provision of eye care and related services in India, Ghana, Uganda, Kenya, Madagascar, Tanzania, Rwanda, Zambia, Mozambique, and Mauritius. The company, through its hospitals, offers services in the areas of cataract, glaucoma, laser correction, cornea and refractive, retina, squint, corneal ulcer, fungal keratitis, diabetic retinopathy, retinal detachment, nystagmus, ptosis, conjunctivitis, retinopathy prematurity, macular hole and edema, cornea transplantation, behcets, computer vision syndrome, hypertensive retinopathy, black fungus, traumatic cataract, keratoconus, uveitis, pterygium, blepharitis, posterior subcapsular cataract, rosette cataract, and congenital glaucoma. Dr. Agarwal's Eye Hospital Limited was founded in 1957 and is based in Chennai, India. Dr. Agarwal's Eye Hospital Limited operates as a subsidiary of Dr. Agarwal's Health Care Limited.

READ MORE ›
₹4,966.50
+3.73% 1Y

Market & Price

Market Cap
-
Current Price
₹4,966.50
High / Low (52W)
₹5,174.80 / ₹4,787.85
Beta
-0.51

Valuation

Stock P/E
-
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
₹668.22
Price to Book
7.43
P/S
-
EV/EBITDA
18.11
Dividend Yield
-

Profitability & Returns

ROCE
-
ROE
25.22%
ROA
9.03%
Profit Margin
14.89%
Op Margin
18.03%
EPS (Latest Qtr)
₹-
EPS (TTM)
₹-

Balance Sheet & Liquidity

Debt/Equity
0.94
Quick Ratio
1.03
Current Ratio
1.23
Debt
₹326.13 Cr
Total Assets
-
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
79.67%
Chg in Prom Hold
-
FII / Inst Holding
1.75%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
₹2,630.83 Cr
Total Revenue (TTM)
₹470.87 Cr
EBITDA
₹145.31 Cr
Free Cash Flow
₹15.20 Cr
Operating Cash Flow
₹145.14 Cr
Shares Outstanding
-
Gross Margin
45.93%
Payout Ratio
-

Growth (CAGR)

Revenue 5Y
-
Profit 5Y
-
Revenue (YoY)
20.20%
Earnings (YoY)
-1.20%

PROS

  • Strong return on equity of 25.2%.
  • Generates positive free cash flow.

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

Price Chart

NSE TradingView Screener.in

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Ad space

Shareholding Pattern

Insiders
79.67%
Institutions
1.75%
Public Float
8.61%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for DRAGARWQ

No recent headlines available.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks